Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates
about
Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates
description
scientific article published on 10 January 2019
@en
name
Consolidation therapy with the ...... the absence of bisphosphonates
@en
type
label
Consolidation therapy with the ...... the absence of bisphosphonates
@en
prefLabel
Consolidation therapy with the ...... the absence of bisphosphonates
@en
P2093
P50
P356
P1476
Consolidation therapy with the ...... the absence of bisphosphonates
@en
P2093
Athanasios Papatheodorou
Despina Fotiou
Dimitrios Christoulas
Evangelos Eleutherakis-Papaiakovou
Magdalini Migkou
Maria Roussou
Nikolaos Kanellias
P304
P356
10.1002/AJH.25392
P50
P577
2019-01-10T00:00:00Z